Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
24.12B | 23.84B | 23.33B | 18.62B | 14.68B | 16.18B | Gross Profit |
2.18B | 1.74B | 2.65B | 2.24B | 1.39B | 2.54B | EBIT |
97.00M | -390.00M | 625.00M | 363.00M | -197.00M | 870.00M | EBITDA |
1.39B | 1.16B | 2.02B | 977.00M | 430.00M | 1.46B | Net Income Common Stockholders |
527.00M | 200.00M | 986.00M | 1.02B | 138.00M | 932.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
5.42B | 6.87B | 3.20B | 8.29B | 11.72B | 10.43B | Total Assets |
61.51B | 64.18B | 58.52B | 50.42B | 48.81B | 43.80B | Total Debt |
3.82B | 4.71B | 718.00M | 777.00M | 730.00M | 62.00M | Net Debt |
-1.60B | -2.15B | -2.42B | -7.42B | -9.89B | -9.86B | Total Liabilities |
17.28B | 20.91B | 13.94B | 12.13B | 11.71B | 7.62B | Stockholders Equity |
44.23B | 43.27B | 44.58B | 38.29B | 37.10B | 36.18B |
Cash Flow | Free Cash Flow | ||||
0.00 | 1.95B | -6.22B | -3.74B | 497.00M | -1.79B | Operating Cash Flow |
0.00 | 4.27B | -4.38B | -1.82B | 1.75B | -1.00B | Investing Cash Flow |
0.00 | -3.14B | -388.00M | -292.00M | -1.44B | -638.00M | Financing Cash Flow |
0.00 | 2.59B | -304.00M | -325.00M | 442.00M | -234.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | ¥138.15B | 16.61 | 7.89% | -7.59% | 18.77% | ||
70 Outperform | ¥192.58B | 10.98 | 4.92% | -8.67% | 40.83% | ||
69 Neutral | ¥106.05B | 16.15 | 3.75% | 2.61% | -9.10% | ||
68 Neutral | ¥276.55B | 10.79 | 3.22% | 12.29% | 59.70% | ||
66 Neutral | $4.47B | 12.21 | 5.40% | 3.65% | 4.14% | -12.00% | |
63 Neutral | ¥86.95B | 15.26 | 2.90% | 10.88% | -29.60% | ||
60 Neutral | ¥15.33B | 76.44 | 1.43% | 2.19% | -79.60% |